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in a diabetic patient. The logical application of such observations, based on the knowledge of
the common patterns of occlusive lesions associated with PAD and the limitation in walking dis-
tance they commonly produce, can lead to a presumptive clinical diagnosis .? This can be con-
firmed objectively as described in subsequent sections, by noninvasive testing in the form of seg-
mental limb pressures, plethysmography, and the occasional , selective use of duplex scanning.
This stepwise approach allows proper management to be chosen in most cases without the need
for angiography.
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B 2.2 Investigation of Patients With Intermittent Claudication
B 2.2.1 Routine Tests
The investigations discussed in this section should be performed on all patients presenting to a
physician for the first time with IC. In the absence of a recent abrupt change in clinical status,
any test that has already been performed in the previous months need not be repeated but
should be noted. They are designed to detect treatable risk factors or to diagnose associated dis-
eases, which have been discussed in an earlier section.
Basic hematologic and biochemical studies
These should include a complete blood count (CBC; includes red cell parameters, white cell
count) and a platelet count. The rationale for this is that, although the hemoglobin or hemat-
ocrit will detect anemia or polycythemia, either of which may precipitate or aggravate the symp-
toms of claudication, a CBC will also detect associated hematologic diseases (eg, chronic myel-
ogenous leukemia) that may be unsuspected yet influence treatment. The same can be said for
an abnormally high or low platelet count, but a baseline platelet count is also useful for compar-
ison, should the patient be subsequently found to have a thrombocytopenia after treatment with
heparin.
In addition, a fasting blood glucose level (FBG) or hemoglobin Alc (HbAlc) and a creatinine
level should be obtained on all new, previously unstudied patients. Diabetes is a significant risk
factor in PAD and may be occult for some time in type II diabetic patients. Urinalysis for glyco-
suria/proteinuria also can be used to detect diabetes. Similarly, azotemia and raised blood urea
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nitrogen (BUN) are insidious, and reduced renal function is common in two of the major risk
factors for PAD, diabetes and hypertension, whether of renovascular origin or not. BUN and
creatinine measurements are also required before angiography or any imaging studies requiring
contrast media.
Blood lipid studies
Patients with claudication have systemic atherosclerosis and are at risk for fatal and nonfatal MI
and stroke. In PAD, the major lipid risk factors for atherosclerosis are elevated low-density
lipoprotein (LDL) cholesterol and triglyceride levels and low HDL cholesterol levels. Lp(a) is a
lipoprotein fraction that is an independent risk factor for PAD, but there is no specific treatment
for elevated Lp(a) levels except to treat abnormalities in other lipid fractions aggressively. Recent
trials support the observation that lipid modification can be associated with stabilization or
regression of femoral atherosclerosis. 1,2,3 Although lipid modification in patients with CAD is
associated with a reduction in the risk of vascular death, similar trials have not been conducted
in patients with claudication, although it may be presumed that a similar benefit exists. It is rec-
ommended that a screening lipid profile be obtained in all patients with PAD. This consists of
total cholesterol, HDL cholesterol, and LDL cholesterol concentrations (the latter being calcu-
lated, not measured) as well as the triglyceride concentration. This aspect is discussed in greater
detail later in this document (see B 4.1.2, Basic Treatment, p 580).
Other selected studies
Although it cannot be justified as a routine screening test, the erythrocyte sedimentation rate
(ESR) is a simple and useful test in patients with PAD. Although it is increased in a wide range
of acute and chronic inflammatory conditions, many of these are vascular disorders, and a nega-
tive test rules these out, whereas a positive test deserves further study. For example, all types of
hyperfibrinogenernia increase the ESR beyond the normal range, and therefore this is much
simpler than measuring plasma fibrinogen itself in screening for hyperfibrinogenemia. An ESR
also will detect hyperviscosity syndromes caused by abnormal proteins such as myelomatosis.
Although a direct measurement of plasma viscosity is more appropriate for detecting such condi-
tions, this is currently not widely available.
Some additional studies may be dictated by abnormalities in the initial routine tests, for exam-
ple, plasma fibrinogen, plasma viscosity, creatinine clearance, or a bone marrow biopsy. Beyond
this, the main reason to obtain additional blood tests on a newly presenting claudicant is a sus-
picion of a hypercoagulable state. Hypercoagulable state (or "thrombophilia") is a term used to
denote a number of clotting abnormalities leading to an increased tendency to thrombosis.
These can be inherited or acquired. These are listed in Table 13. The former include deficiencies
in protein C, protein S, and antithrombin and activated protein C resistance or presence of fac-
tor V Leiden, the latter now the most common hereditary risk factor for DVT, being present in
approximately 5% of the white population.e-f
Originally, these clotting abnormalities were thought to be associated only with abnormal
venous thrombosis and were seen at an early age,8 as is generally true of homozygous states.
There is now good evidence that they also may be found, as heterozygous states, in older
patients with PAD. Importantly, hypercoagulable states are frequent (up to 40%) in patients
undergoing revascularization procedures and even more frequent in those with failed vascular
intervention.s Finally, protein C deficiency can lead to serious complications if coumarin is
administered without preliminary heparinization." These findings underscore the potential
importance of screening patients for hypercoagulable states.
In addition to inheritable clotting abnormalities, there are a large number of acquired hyperco-
agulable states (some of the better known of these are included in Table 13). Antithrombin
deficiency may be acquired, most often in chronic debilitating diseases in which there is poor
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Table 13. Types of hereditary and acquired hypercoagulable states
Well-provCII hereditaryhypel"coagulable states
Factor V Leiden mutation (APe resistance)
Protein C deficiency
Protein S deficiency
Antithrombin deficiency
Dysfibrinogenernia
Prothrombin mutation
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Well-described acquired IJYpercoaglllable states
Antiphospholipid syndrome
Cancer-associated ("Trousseau's") thrombosis
Thrombosis associated with inflammatory bowel disease
Antithrombin deficiency due to low-protein states (eg, protein-losing enteropathy, nephrotic syndrome, malnutrition)
Hyperhornocysteinernla due to folic acid or vitamin B12 deficiency (diet/absorption)
Presumedinheritable hypel"coaglilable states (controversial/nos yet sufftcimtly wellcharacterized)
Plasminogen deficiency
Abnormal plasminogen
Plasminogen activator deficiency
Factor XII deficiency
Abnormal platelet reactivity
nutrition and protein loss or deficits. Hyperhomocysteinemia is more commonly inherited but
can be acquired, if the intake or absorption of folic acid is deficient. Both are more likely to be
encountered in those with severe leg ischemia, in which uncontrolled pain and poor nutrition
go hand in hand, than in patients with IC.
Heparin-induced thrombocytopenia is more likely to be encountered in those presenting with
acute thrombotic events and acute ischemia but can develop in any patient being treated with
heparin or exposed to heparin through indwelling catheters. However, in patients presenting newly
with claudication, only the presence of lupus anticoagulant, antiphospholipid antibodies, myelo-
proliferative disorders, and certain malignancies are likely to be of much clinical significance.
Although heparin-induced thrombocytopenia produces a low platelet count and some cases of
lupus anticoagulant are detected by an elevated partial thromboplastin time (PTT), the routine
blood clotting tests performed in most laboratories (eg, prothrombin time [PT], PTT, platelet
count) do not effectivelydetect the presence of a hypercoagulable state. Although they should
be obtained in patients considered for invasive interventions, they are not indicated in all
patients presenting with claudication. However, a "hypercoagulable profile" should be obtained
in individuals with a personal or family history of thrombotic events, early age of onset «45
years), or the absence of any of the usual risk factors for PAD, including a family history of ath-
erosclerotic complications. Similarly, patients with a low platelet COLlnt and a history of exposure
to heparin (as treatment or in association with indwelling catheters) who present with a new
occlusive event should be investigated for heparin-induced platelet antibodies. Although sero-
tonin release assays have been employed, the classic test involves demonstration of aggregation
of normal (pooled) platelets by the patient's own platelet-poor plasma in the presence of
heparin.
These confirmatory tests are expensive and should be selectively ernployed.? They usually consist
of a thrombin time, PT, PTT, plasma fibrinogen and plasminogen levels, a euglobulin lysis time,
assays for proteins C and S and antithrombin, an anticardiolipin antibody level, and a Dilute
Russell Viper Venom Test (DVVT) (to screen for antiphospholipid antibodies). Activated pro-
tein C resistance is tested using a modified method that gives meaningful results in all clinical
circumstances. This is a much less expensive screen for factor V Leiden. If the results of one or
more of these tests are positive, an additional tier of tests may be required to pinpoint the diag-
nosis, such as crossed immunophoresis, C4B binding protein, factor V Leiden assay, or the
activities of tissue plasminogen activator or its inhibitor. These are outlined in Table 14.
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Finally, although the homozygous forms of homocysteinuria and homocysteinemia have been
recognized for some time to be associated with premature-onset PAD,lO increasing evidence
links the heterozygous state with increased risk of PAD. Elevated plasma homocysteine levels are
associated with a faster rate of progression of PAD and are now considered by many to be an
independent risk factor for PAD.ll Therefore, plasma homocysteine levels should be obtained
on any patient presenting with claudication who does not have any of the previously mentioned
usual risk factors associated with PAD.
Table 14. Typical tests used in identifying hypercoagulablc states"
Primary Tests Additional Tests
Thrombin time Heparin-induced platelet antibodies
Prothrombin time
Activated partial thromboplastin time
Platelet count Platelet adhesiveness & aggregability
Platelet aggregation test for HITT
Plasma fibrinogen level
Plasminogen level
Euglobulin lysis time (screens for abnormalities in the fibrinolytic system)
Protein C assay/activiry
Protein S assayjactiviry Crossed immunoelectrophoresis
Antithrombin assay/activity
Tests for antiphospholipid antibodies or lupus anticoagulant
Anticardiolipin antibody assay (IgG, 19M)
Dilute Russell Viper Venom Test
Resistance to activated protein C Assay for Factor V Leiden (screens for factor V Leiden)
Abbreviation: HITT, heparin-induced thrombosis and thrombocytopenia.
*These tests are used in variable combinations in stepwise screening.
Recommendation 13: Reconunended laboratory tests for new patients with intermittent
claudication
The following blood tests should be performed in all new patients presenting with
intermittent claudication:
• Complete blood count (hemoglobin, hematocrit, white cell count)
• Platelet count
• Fasting blood glucose or hemoglobin Alc
• Creatinine
• Fasting lipid profile
• Urinalysis (for glycosuria/proteinuria)
Recommendation 14: Additional laboratory investigations for atypical patients
The following laboratory investigations should be performed selectively in atypical
patients (eg, those with early age of onset, atypical distribution of occlusive lesions, per-
sonal or family history of thrombotic events, lack of any of the common risk factors for,
or a family history of, atherosclerosis, unexpected failed interventions):
• HypercoaguIability screen
• Homocysteine levels
Evaluation for atherosclerosis in other regional circulations
Further initial investigations are indicated, bearing in mind that patients with IC are at particu-
larly high risk of atherosclerotic disease affecting other parts of the circulation. PAD, due as it is
to atherosclerosis, is rarely an isolated disease process. Close to one third of patients with PAD
have clinically significant coronary atherosclerosis.P and in those who are c1audicants it is often
masked by exercise restrictions. Occult MI is not uncommon, and a resting ECG should be rou-
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tinely obtained on ali new patients with IC if no recent report is available. This is essential in
those patients considered for intervention, and in some of these, an additional diagnostic test for
occult coronary disease such as persantine thallium cardioscintigram or dobutamine echocardio-
gram is indicated. An ECG on first presentation will not only detect evidence of occult infarct
or unsuspected arrhythmias but serves as a valuable baseline for future comparison.
Approximately one fourth of PAD patients have hypertension, and in these consideration should
be given to the possibility of renal artery narrowing. Finally, approximately 10% to 15% have
cerebrovascular disease, mostly in the form of carotid stenosis. Clearly, if a patient has a history,
symptoms or signs, or ECG evidence of cardiac disease, he or she will need a referral to a cardi-
ologist and further investigations (either noninvasive screening studies or, in some instances,
coronary angiography). Coronary disease takes clear priority over claudication in the overall
management of the patient. The same applies to the investigation and treatment of previously
unsuspected hypertension, because better screening tests for renovascular disease are now avail-
able. 13,14 Ifa patient describes symptoms of transient cerebral ischemic attacks or has a carotid
bruit, a duplex scan of the carotid bifurcation will detect any carotid artery stenosis or occlusion
with reliable accuracy.IS There is ongoing controversy about the value of screening all patients
with IC, symptomatic or not, for carotid disease and aortic aneurysms. 16,17 There is no doubt
that claudicant patients are more likely to have significant asymptomatic disease in these areas
than the general population, but the treatment of asymptomatic carotid disease is still controver-
sial, and there is the issue of yield versus cost of such screening tests.
Recommendation 15: Investigating other regional circulations in peripheral arterial disease
A baseline resting electrocardiogram is recommended in new patients with intermittent
claudication, but in the absence of family history, risk factors, or suggestive symptoms
or signs, there is as yet no good evidence for routine further investigation of other cir-
culations in such patients.
Patients with peripheral arterial disease have a high associated prevalence of coronary,
cerebrovascular, and renal artery disease. Patients with symptoms or signs suggesting ath-
erosclerotic disease in other regions will need further investigations and special assessment.
Critical Issue 3: Screening for asymptomatic coronary, carotid, and aortic aneurysmal dis-
ease in patients with intermittent claudication
The cost-effectiveness of screening c1audicants for occult coronary artery, internal
carotid, or aortic aneurysmal disease needs to be evaluated.
Ankle pressure measurements
Measuring the pressure in the ankle arteries has become a standard part of the initial evaluation of
patients with PAD, including patients with IC. A sphygmomanometer cuff above the ankle with a
Doppler probe over the posterior tibial or dorsalis pedis arteries is used to detect the return of flow
after cuff deflation, that is, the systolic pressure. Although the absolute pressure correlates well with
symptoms, it is better standardized against the highest brachial pressure, called the ankle:brachial
pressure index (ABPI), which serves as a baseline for comparing the patient with himself/herself at
different times. There are several advantages to obtaining the ABPI on the initial visit. First, it
objectively confirms or rules out the existence of hemodynamically significant occlusive disease
between the heart and the ankle, which in almost all cases lies distal to the renal arteries, Second, it
provides a rough measure of the severity of the occlusive disease for correlation with the patient's
symptoms. Third, it can serve as an aid in differential diagnosis, in mat patients with exercise-related
leg pain of other causes will either have a normal ankle pressure or a degree of reduction which does
not fit with the severity of disability. Finally, the ABPI can detect lesser disease in the contralateral
extremity, which may not be suspected because it is masked by the more severe symptomatic leg.
However, studies of the variability of ABPI measurements between observers with varying
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degrees of training and experience have shown that it should be measured by experienced per-
sonnel.lf The variability is partly related to the two pressure measurements required for the
index. The reproducibility of the ABPI varies in the literature,19,20 but it is significant enough
that reporting standards require a change of 0.15 in an isolated measurement for it to be con-
sidered clinically relevant, or greater than 0.10 if associated with a change in clinical status.U
For the same reasons, even though the ABPI is normally greater than 1.0 in normal patients,
the cut-off point when screening for occult PAD in large population-based studies is less than
0.90 at rest. The comparison of the resting ABPI with that recorded after a degree of exercise
that produces pain provides useful information and is described in the next section.
Recommendation 16: Ankle:Brachial Pressure Index in intermittent claudication
The ankle:brachiaI pressure index (ABPI) should be measured in both legs in all new
patients with intermittent claudication.
B 2.2.2 Special Investigations Other Than Imaging
The primary justification for special investigations in the claudicant is where they contribute sig-
nificantly to accuracy of diagnosis, or supply needed information that affects the further man-
agement of the patient. This is particularly the case if it helps determine the need for and feasi-
bility of, different forms of interventional therapy. In many instances, the simpler noni..nvasive
tests, such as segmental limb pressure determinations, may be justified on the grounds mat they
more accurately characterize the location and severity of the occlusive lesions.
In contrast, the more invasive and expensive of these tests, angiography, is not routinely used in
patients with IC, whereas it is frequently applied to those with CLI, in which the consideration
of limb loss and intervention to prevent it apply in almost every case. Most of the investigations
described in later sections are intended to characterize the underlying anatomic lesions or the
hemodynamic changes they produce. They basically consist of either physiological testing or vas-
cular imaging, the latter using noninvasive or invasive methods (eg, duplex scanning or contrast
angiography). It should be noted that common practice in relation to noninvasive investigations
used in patients differs widely between Europe and North America. For example, segmental
limb pressures (SLP), pulse volume recordings (PVR), and velocity waveform analysis (VWF)
are much more widely used in North America, where mere is already considerable experience in
their use and interpretation. In Europe, however, a preferred alternative to these tests is duplex
scanning.
Segmental limb systolicpressure measurement (SLP)
SLP is now widely used because it accurately detects and segmentally localizes hemodynamically
significant large-vessel occlusive lesions in the major arteries between the heart and the measur-
ing point. One such pressure measurement, the ankle pressure, is so routine that it has been
already discussed under basic investigations. Segmental measurements at other levels down the
leg (upper and lower thigh and calf), in addition to the ankle, are obtained in the same fashion
as the ankle pressure (AP). A sphygmomanometer cuff is placed at a given level wi.th a Doppler
probe over one of the pedal arteries, and the systolic pressure in the major arteries under the
cuff is measured. The location of occlusive lesions is apparent from the pressure gradients
between the different cuffs. 22
Although some prefer a single large, wide thigh cuff because of its low false-positive rate, such a
cuff straddles the femoral bifurcation and therefore does not distinguish well between proximal
(iliac) and distal (fernoropopliteal) disease, which upper and lower thigh cuffs of regular width
do more accurately.t-' Thc latter cuffs, however, give an artifactual high upper thigh pressure, by
25% or more, because of the girth of the upper thigh relative to the cuff's width, but this is
worth adjusting for, in exchange for a better separation of proximal and distal disease. The accu-
racy of this test alone in detecting and localizing occlusive lesions has been reported to be 85%,
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blinded against angiography.-t The main problems are (1) missing isolated moderate stenoses
(usually iliac) that produce little or no pressure gradient at rest and (2) falsely elevated pressures
in diabetic patients with calcified, incompressible arteries.If
Special considerations in evaluating diabetic patients
Patients with long-standing diabetes commonly develop calcified, incompressible vessels, which
cause false high SLP measurements, particularly at the ankle level. The prescnce of this artifact is
obvious when the measured SLP are all unbelievably high (eg, 300 mm Hg) or ABPI is greater
than 1.5, but subtler degrees can be misleading. The usual clue is that the SLP readings arc
much higher than brachial pressure and increase from thigh to ankle rather than gradually
decrease, as they normally do. This is because the more distal (crural) arteries are usually more
severely involved, and at times only the AP is falsely elevated. Although the frequency of false
pressure measurements in diabetic patients has probably been exaggerated in the past, it remains
a significant problem.s? A partial solution, a substitute for a falsely elevated AP, is to measure
the toe pressure. A special small occlusion cuff is used proximally on the first or second toe with
some flow sensor, such as digital plethysmography using a light-emitting diode, beyond it.27
This is feasible because, even in long-standing diabetes, the more distal pedal vessels are usually
not calcified and therefore compressible.
The toe pressure is normally approximately 10 mm Hg less than the ankle pressure. But, like
ankle pressures, measuring toe pressures as an isolated test is more useful in assessing patients
with eLI than those with claudication. For that reason, it is described in more detail later, in
the appropriate section. Furthermore, measuring toe pressures does not help localize occlusive
lesions proximal to that point. That is, it can substitute an ankle pressure but does not solve the
problem of falsely elevated SLP measurements proximal to that point. This can be overcome by
segmental plethysmography or pulse volume recordings (PVRs; see next section), and this
approach is helpful even if segmental limb pressures can be accurately measured.
Segmental plethysmography or pulse 'Volume recordings (PVR)
A plethysmograph is any instrument that detects and graphically records volume change. To
perform segmental plethysmography, any instrument that measures the relative change in vol-
ume associated with each cardiac cycle in the segment of limb encircled by a plethysmographic
sensor may be used. Although mercury-in-silastic tube strain gauges or impedance strips encir-
cling the limb at selected levels can be used, in common practice calibrated air-filled cuffs, much
like sphygmomanometer cuffs, are employed. They are placed around the leg at selected loca-
tions and connected to a plethysmograph, which produces a "pulse volume recording" (PVR).28
Normally a single large thigh cuff is used along with regular-sized calf and ankle cuffs, plus a
brachial cuff, which reflects the undampened cardiac contribution to arterial pulsatiliry, The lat-
ter is useful in standardizing the lower-limb PVR and in detecting poor cardiac function as a
cause of low-amplitude tracings. By comparing the magnitude and contour of each PVR with
that recorded at the proximal or distal cuff, whether there is a significant occlusive lesion
between them can be determined.
In the study cited above, both SLP and PVR measurements alone were 85% accurate compared
with angiography in detecting and localizing significant occlusive lesions.24 Furthermore, when
used together in a complementary fashion, they were over 95% accurate. For this reason, these
two diagnostic methods are often used together when evaluating PAD. By using them in combi-
nation, diabetic patients with calcified arteries sufficient to produce falsely elevated SLP will be
readily recognized and correctly assessed by PVR.
Doppler Velocity Wave Form (VWF) analysis
This is used in some Vascular Diagnostic Laboratories, instead of PVR, to complement SLP.
Here, arterial VWF is recorded using a continuous-wave Doppler over the femoral, popliteal,
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posterior tibial, and dorsalis pedis arteries. Similar to the interpretation of PVR, qualitative dif-
ferences in the magnitude and contour ofVWF between two adjacent recording points identifies
the presence of an occlusive lesion in the intervening arterial segment.s? This may even be
quantified for greater accuracy.30 However, VWF recording and analysis is very operator depen-
dent, and for that reason PVR are preferred by most. VWF analysis is not widely used in
Europe.
These tests are painless, quick, inexpensive, and accurate enough in detecting and localizing
arterial occlusive disease in most cases, that vascular imaging is only occasionally necessary in
patients with Ie. Their major weakness is that they are based on indirect information and can
identify a hemodynamic occlusive lesion in a particular arterial segment but cannot further char-
acterize it. For example, they cannot distinguish between a tight localizedstenosis and a well-col-
lateralized long occlusion. Because this may well affect the decision to intervene (with PTA),
duplex scanning is called for in these circumstances. Duplex scanning is admittedly more accu-
rate tha.n SLP alone. In a study by Moneta et al,31 duplex was 97% accurate (vs 75% for SLP
alone) in detecting superficial femoral artery lesions with >50% luminal narrowing and 91%
accurate (vs 54% for SLP alone) in detecting similar lesions in the popliteal artery.
It is noteworthy that this comparison was not performed at the iliac and tibial artery levels,
where duplex is much less accurate. Furthermore, the demonstrated advantage is mainly with
lesser degrees of stenosis, of questionable clinical significance , and would not be as great if SLP
had been combined with PVR. Finally, duplex scanning, particularly a complete study of both
lower-extremity arteries, is very time consuming and relatively much more expensive than SLP
and PVR. The recommended applications of duplex scanning are discussed later.
Recommendation 17: Noninvasive localization of lesions
If it is desirable to localize and gauge the severity of occlusive arterial lesions to assist in
planning an intervention; then duplex scanning or magnetic resonance angiography
(depending on local availability, experience, and cost) can be used as a preliminary, non-
invasive examination before angiography. In many cases, the information supplied by
simpler tests such as segmental limb pressure or pulse volume recording is adequate for
decision making.
Functional testing, using treadmill exercise or other means of inducing limb hyperemia
At rest, the lower-extremity arterial circulation is the prototype low-flow, high-resistance circula-
tion. Exercise reverses this, and the high-flow, low-resistance hemodynamics that result either mag-
nify resting pressure gradients associated with occlusive arterial lesions or produce them where
undetectable by resting studies. Measuring the pressure gradients, typically the change in the ABPI
associated with a standardized exercise protocol, or those produced by other forms of induced
hyperemia, is the best accepted method for quantifying function and disability in patients with Ie.
Although these pressure gradients can be measured between monitoring cuffs at any level, just as
with resting SLP, for practical reasons only brachial and ankle cuffs are routinely used.
The usual treadmill exercise test to assess the hemodynamic significance of arterial occlusive dis-
ease in the lower extremities is performed in a vascular diagnostic laboratory. The patient walks
at a standard speed and grade on a treadmill until claudication pain is experienced or a time
limit has been reached, for example, 5 minutes at 3.5 km/h on a 12%incline. The latter is
equivalent to walking nearly 600 meters at average speed. With a significant arterial occlusive
lesion, there will be a significant decrease in the ABPI from resting to the postexercise level,
normally measured 1 minute after exercise. Even in patients with known pulse deficits, other
conditions (eg, arthritis) can be the cause of the discomfort experienced with exercise; therefore,
it is important to note the degree of drop in ABPI in this test.
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If ischemia is causing the pain that terminates the test, the post-exercise ankle pressure should
be considerably lower than the resting value, often in the range of 50 mm Hg. In severe cases,
the ABPI may be unrecordable for several minutes. This "treadmill test" is not to be confused
with that used in screening for coronary disease, in which the patient is pushed well beyond the
limits of usual walking. Similarly, it should not be confused with the treadmill protocols used in
gauging walking distance during clinical trials of the efficacy of pharmacotherapy and other
treatments. These have been mentioned earlier in Outcome Assessment Methodology (A3, p
535) and is described again in detail later in Clinical Trial Issues (B6, p 5127).
Alternative stresstests
Some elderly or otherwise disabled patients cannot perform treadmill exercise, and treadmills
are not universally available, so alternative methods of simulating these hemodynamics have
been tried. To overcome the unavailability of a treadmill, some centers have timed patients walk-
ing in adjacent corridors until claudication develops, and then they record the ankle pressure.
Unfortunately, even when the patient is accompanied by a technician, walking speed is quite
variable.
A second alternative is to inflate a thigh cuff well above systolic pressure for 3 to 5 minutes,
producing a similar degree of "reactive" hyperemia.V The decrease in AP 30 seconds after cuff
deflation is roughly equivalent to that observed 1 minute after walking to the point of claudica-
tion on a treadmill.V Unfortunately, many patients do not tolerate the discomfort associated
with this degree and duration of cuff inflation. Dorsiflexion of the foot with the leg elevated 30°
also has been used, but it does not produce nearly the same degree of pressure drop.
B 2.2.3 Imaging Techniques
Indications for imaging in patients with intermittent claudication
Imaging is indicated if some form of intervention would be advised if a suitable lesion is demon-
strated. This is covered in detail later in Overall Strategy (p 577), but it deserves brief comment
here for emphasis. The decision regarding the appropriateness of intervention is arrived at by
balancing the patient's disability against the immediate risks and long-term benefits of a particu-
lar intervention compared with other alternatives, such as regular exercise training or pharma-
cotherapy. The patient's disability can and should be assessed at the initial visit. This is consid-
ered in terms of not only claudication distance but how this limitation affects the patient's
lifestyle, as well as independence and self-care-in other words, everyday living requirements
and preferences.
The detailed risks and results of catheter procedures and vascular reconstruction are considered
in Endovascular Procedures (p 597), but clearly the risks of PTA are considerably less than the
risks of a surgical reconstruction. Therefore, the indications for intervention, and thus imaging
as well, have significantly increased in the last 10 to 15 years. Similarly, the expense and morbid-
ity rate for duplex scanning are far less than for angiography, and with the introduction of color
coding and other technological advances, it is now possible to use Duplex scanning in many sit-
uations to assess the suitability of the underlying lesions for the proposed intervention before
committing to angiography.
The clinical examination of the patient may give some indication as to whether a suitable lesion
for percutaneous intervention is likely to be found. For example, if a patient has full, easily pal-
pable pulses at the level of the popliteal, it is most unlikely that imaging will show a lesion that
can be easily and safely treated by percutaneous techniques, that is, the disease is in the crural
vessels. By contrast, if a patient has a diminished femoral pulse and a proximal bruit, the disease
is most likely to be a narrowing of the iliac arteries. In this case, some form of catheter proce-
dure may be feasible and appropriate. The same may be said for noninvasive physiological test-
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ing. However, such tests primarily localize occlusive lesions and assess their relative hemodynam-
ic significance without distinguishing between a tight stenosis and a complete occlusion. Here
duplex scanning may add valuable information, distinguishing, for example, between a short dis-
tal SFA stenosis and a long complete occlusion. The former is suitable for PTA; the other
req uires bypass. Thus, proper application of imaging techniques provides the firmest foundation
for the decision to intervene.
Choice of imaging methods
The main reason to image the arteries supplying the claudicating leg is to find and define an
arterial lesion that has a suitable morphology for some form of intervention, radiological or sur-
gical. The current options are angiography, duplex scanning, or some form of magnetic reso-
nance imaging (MRI/MRA).
Angiography
Angiography carries a certain morbidity risk (approximately 0.1% risk of severe reaction to con-
trast medium,34 0.7% complications risk severe enough to alter patient management, and 0.16%
mortality risk35) and significant additional expense, as well as being an unpleasant experience for
many patients. adler studies quote lower mortality rates (see B 4.1.1, Overall Strategy, p S77).
These problems have been gready mitigated by technological improvements such as nonionic
contrast agents, digital subtraction angiography, intraarterial pressure measurements across a
stenosis with and without vasodilators.Jv and more sophisticated image projection and reten-
tion, etc. Alternatively, carbon dioxide can be used instead of conventional contrast media. In
high-risk (eg, renal impairment) and other selected patients, restriction to a partial study with
selected views rather than visualizing the entire infrarenal arterial tree has decreased the contrast
load, length of study, and associated risks.37,38 Nevertheless, full angiography, with visualization
from the infrarenal aorta to the pedal arteries using digital subraction angiography (DSA) tech-
niques, remains the choice in most cases.
Recommendation 18: Indications for angiography in intermittent claudication
Angiography in a patient with intermittent claudication is usually indicated only when a
decision has been made to intervene, should a suitable lesion be identified.
Color duplex imaging
Color duplex imaging has been proposed as an attractive alternative to angiography in that it
does not share many of its disadvantages. In addition to being completely safe and much less
expensive, duplex scanning, in expert hands, can provide most of the essential anatomic infor-
mation plus some functional information-for instance, velocity gradients across stenoses. The
lower extremities' arterial tree can be visualized, with the extent and degree of occlusive lesions
accurately assessed and arterial velocities measured. The disadvantages of color duplex scanning
are that there are too few sufficiently trained personnel for it to be widely available; obtaining
information similar to angiography is dependent on the duplex operator. Purthermore, there is
no hard copy equivalent to an arteriogram. Although multiple Polaroid images or videotapes
can be made, they are not useful in actual practice. The latter, plus the extra security of being
able to view the entire arterial tree in fine detail, means that most vascular surgeons require
angiography before undertaking a vascular reconstruction.
This is not the case if percutaneous revascularization (eg, balloon angioplasty or atherectomy) is
to be undertaken, because such procedures inevitably involve concomitant arteriographic imag-
ing of the relevant vessels. Thus, duplex scanning can serve as a screening test for many
catheter-based interventions. However, because SLP and PVR are quicker and cheaper, and sup-
ply much of the information required for decision making, even when PTA is contemplated,
there is little justification for duplex scanning of the entire extremity arterial tree, particularly in
patients with IC. In this setting, duplex scanning is usually applied selectively, in the same vascu-
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lar laboratory and at the same time as SLP and PVR, interrogating just those segments where
additional information is needed, usually searching for discrete lesions amenable to percutaneous
revascularization techniques.
To summarize, if a patient qualifies for invasive therapy, angiography will ultimately be required
in almost all elective cases, preoperatively for surgical reconstruction, and before or during
catheter-based interventions. Duplex scanning is used selectively mainly to characterize specific
lesions in regard to their suitability for endovascular treatment. However, it should be kept in
mind that arterial reconstructive surgery can be performed on the basis of duplex scanning
alone in some cases.39,40 This not only has value for those who are allergic to contrast media,
but it offers potentially significant cost savings. Therefore, improved technology, wider training
of surgeons as well as technicians, and cost considerations should increasingly promote this
approach in the future.
Magnetic Resonance Angiography (MRA)
The other possible future scenario is that MRA may become the preferred imaging technique, as
a practical compromise between duplex imaging and angiography, although with current tech-
niques it tends not to distinguish well between tight stenoses and complete occlusions.
However, for at least aortoiliac disease, some studies have shown that the best MRA techniques
are adequate for stenosis qualification and discriminating between stenosis and occlusion.41,42,43
In some cases MRA (especially with contrast enhancement) may be as good as conventional
angiography.44,45,46,47,48 Further studies are needed to determine to what extent MRA may
replace angiography.
Spiral Computed Tomography (CT)
Spiral CT is also being used for the noninvasive evaluation of proximal, that is, aortoiliac occlu-
sive, disease.
Critical Issue 4: Alternative investigations to angiography
Further studies are needed to determine to what extent duplex scanning, magnetic reso-
nance angiography, or other new imaging modalities may replace angiography for many
applications in the future.
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B 3 Outcome Assessment of Intermittent Claudication in Clinical Practice (see also A
2.2, Intermittent Claudication, p 85)
A detailed assessment of outcomes necessary for clinical trials or published studies is discussed in
B6, Clinical Trial Issues (p SI27). IC is an indicator of not only blood flow-limiting lesions
within the arterial tree of the lower extremity but also clinically significant systemic atherosclero-
sis. As such, LC exerts a global impact on the patient. Patients so afflicted experience broad
limitations in their level of daily functioning that extend beyond the ambulatory disability. Using
a variety of quality-of-life assessment instruments, such as the SF-36 and the Nottingham
Health Profile, investigators have documented increased bodily pain and decreased physical,
emotional, social functions, and worse perceived health as well as a variety of other disturbances
in patients with claudication compared with age-matched controls.l,2,3,4,5
Appropriate therapeutic goals for the treatment of the claudicant must address both the specific
lower-extremity disability and the systemic impact of the disease. Ideally, treatment will result in
an improvement in both the vascular status of the lower extremity and the patient's general
health status, indicated by at least four attributes on the SF-36 or RAND-36, and level of func-
tioning, indicated by at least two attributes on the WIQ. The complete assessment of the out-
comes of treatment of the claudicant, therefore, requires the use of both clinical and patient-
based parameters. It is impossible to define "relevant" improvement.
Recommendation 19: Success of treatment for intermittent claudication
Ideally, success of treatment for intermittent claudication should take into account an
improvement in the following:
• Objective outcome: relevant improvement in walking distance as measured by a stan-
dardized exercise test
• Symptomatic outcome: improvement on a validated disease-specific health status
questionnaire
• General quality of life: improvement on a validated generic health status question-
naire
• Postrevascularization: objective proof of patency of any revascularized segment
(ideally with imaging)
B 3.1.1 Relationship Between Clinical and Quality-of-Life Outcomes Parameters
Despite the performance of a complete clinical evaluation, physicians cannot accurately assess
the overall impact ofIC on the patient. Pell- compared quality-of-life assessments of201 claudi-
cants before their first visit to their vascular surgeon with the surgeon's impression of the
patient's symptoms and examination. The correlation between these two assessments was poor.
Studies evaluating patients with IC by walking distance, ABPI, and quality of life have also
demonstrated a poor or limited correlation between the clinical parameters and quality-of-life
index. Assessing 157 claudicant patients with treadmill walking distance, ABPI, and the
EuroQol generic quality-of-life survey, Chettcr et al6 noted a poor correlation between the clini-
cal parameters of treadmill walking distance and ABPI and the measured quality of life. Barletta
et al? evaluated treadmill performance and the quality of life with the McMaster Health Index
Questionnaire in 251 patients and 89 age-matched controls. These investigators documented a
